(Q44378409)

2 December 2017

Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism (English)

1 reference

2 December 2017

4

1 reference

2 December 2017

1

Agneta Hilding

1 reference

2 December 2017

Kerstin Hall

2

1 reference

2 December 2017

Josefin Skogsberg

series ordinal

3

1 reference

2 December 2017

Moira S Lewitt

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Biochemical and Biophysical Research Communications

2 December 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 December 2017

303

1 reference

2 December 2017

2

1 reference

2 December 2017

693-699

1 reference

Cellular actions of the insulin-like growth factor binding proteins

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Role of the insulin-like growth factors in the endocrine control of glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Insulin-like growth factor binding protein-1: recent findings and new directions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Changes in the IGF-IGFBP axis in critical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Lithium chloride inhibits the expression and secretion of insulin-like growth factor-binding protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

In vitro studies on the action of CS-045, a new antidiabetic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone has a scavenging effect on reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Troglitazone selectively inhibits glyoxalase I gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Effects of troglitazone on HepG2 viability and mitochondrial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Vitamin E activates gene expression via the pregnane X receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Regulation of cyp3a gene transcription by the pregnane x receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

The IGF axis and programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900403-0

10.1016/S0006-291X(03)00403-0

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference